Approval · Notice of Compliance 7664 · 2005
DIFFERIN XP: Notice of Compliance 7664
Issued December 20, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 7664
- Date
- December 20, 2005
- Company
- Galderma Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Provides for a new strength
- Therapeutic class
- Treatment of acne vulgaris
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DIFFERIN XP | 02274000 | Marketed |
Medicinal ingredients
- ADAPALENE 3 PER